SCHEMBL18914760

SCHEMBL18914760

N#Cc1ccc(-c2c3ccccc3c(-c3cc4c(-c5ccccc5)nc5ccc6ccccc6c5c4c4ccccc34)c3ccccc23)c2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
KDM4E B2RXH2 7/20 0.41
LMNA P02545 5/20 0.41
HTT P42858 4/20 0.41
RXFP1 Q9HBX9 1/20 0.41
THRB P10828 1/20 0.41
SLC22A12 Q96S37 7/20 0.39
MAPT P10636 7/20 0.37
HPGD P15428 4/20 0.37
POLB P06746 4/20 0.37
NPSR1 Q6W5P4 3/20 0.37
NPC1 O15118 1/20 0.36
NPY1R P25929 1/20 0.36
NPY2R P49146 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KMT2A Q03164 2/20 0.35
MAPK1 P28482 1/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17037773 0.88 ALDH1A1 (0.48) ALDH1A1KDM4ELMNAHTTRXFP1
SCHEMBL18914565 0.86 ALDH1A1 (0.41) ALDH1A1KDM4ELMNAHTTRXFP1
SCHEMBL18907345 0.85 ALDH1A1 (0.42) ALDH1A1KDM4ELMNAHTTMAPT
SCHEMBL18914725 0.85 SLC22A12 (0.39) ALDH1A1KDM4ELMNAHTTRXFP1
SCHEMBL17037278 0.78 ALDH1A1 (0.45) ALDH1A1KDM4ELMNAHTTRXFP1
SCHEMBL18907207 0.78 KDM4E (0.44) ALDH1A1KDM4ELMNAHTTRXFP1
SCHEMBL17037169 0.77 SLC22A12 (0.43) ALDH1A1KDM4ELMNAHTTRXFP1
SCHEMBL17037340 0.74 ALDH1A1 (0.40) ALDH1A1KDM4ELMNAHTTRXFP1
SCHEMBL17034964 0.74 MEN1 (0.42) ALDH1A1KDM4ELMNAMAPTHPGD
SCHEMBL18748133 0.74 ALDH1A1 (0.41) ALDH1A1KDM4ELMNAHTTRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, OCIAD1, CCNT1 ALDH1A1 195/4885KDM4E 2914/4885LMNA 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.